Thought of the Week: What We Give
July 17, 2025
Thought of the Week – Unafraid
There is much in the world to make us afraid. There is much more in our faith to make us unafraid. (Fredrick W. Cropp)
081123
Related:
Thought of the Week: Dissolving the Pain
July 9, 2025
Thought of the Week: What I Can Do
July 1, 2025
Thought of the Week – Kindness Grows Abundant
June 17, 2025
As I Grow Older
June 11, 2025
Honoring Dad on Father’s Day
June 10, 2025
Email me when people comment
Login
0 Comments
Edited by:
P. Berger
Caring for dementias such as Alzheimer's among family and friends, Peter committed to help preserve the dignity of people affected by Alzheimer's. AlzheimersWeekly.com is the fruit of that commitment.
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
Dementia Books & Videos on Amazon:
More From Alzheimer's Weekly
Progress
Success in Delaying Dementia
PROGRESS: A key study shows an easing, in certain respects, of the harsh impact of dementia. On average, people seem to be developing dementia later
No Comments
Drugs
LEQEMBI® for Alzheimer’s Now in USA, China, Japan, South Korea
South Korea joined other countries in approving LEQEMBI® (generic lecanemab) for mild cognitive impairment, mild and early Alzheimer’s. Learn how Leqembi is treating Alzheimer’s around the world.
1 Comment
Genes
TREM2 Helps Break the Alzheimer’s Code
See Dr. David Samati explain the important connection between the TREM2 gene and Alzheimer’s disease. Read about its significance.
No Comments
Drugs
Leqembi Injection, an Easier Alzheimer’s Treatment, Awaits FDA Approval
LEQEMBI® is the newest Alzheimer’s drug. It is administered in hospitals via IV. Biogen applied to the FDA for approval of a home version using an “Autoinjector”. See how it works and learn its advantages.
No Comments
Share to Facebook
Twitter
LinkedIn
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On